Tempest Therapeutics, Inc. — Form D
Tempest Therapeutics, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-03-01. The offering totals $70.2M, of which $25.2M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2018-03-01
- Form: D
- Accession: 0001533635-18-000003
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $70.2M
- Amount sold: $25.2M
- Remaining: $45.0M
- Investors: 8
- Date of first sale: 2018-02-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-306741
Issuer
- Name: Tempest Therapeutics, Inc.
- CIK: 0001533635
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 7000 Shoreline Court, SOUTH SAN FRANCISCO, CA, 94080
- Phone: (415) 798-8589
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Robert J Weisskoff | Director | Seattle, WA |
| Michael W Raab | Director | South San Francisco, CA |
| Thomas W Woiwode | Director | South San Francisco, CA |
| Petpiboon Prasit | Director | San Diego, CA |
| Petpiboon Prasit | Executive Officer | San Diego, CA |
| Thomas W Dubensky, Jr. | Director | South San Francisco, CA |
| Thomas W Dubensky, Jr. | Executive Officer | South San Francisco, CA |
| Paul W Grayson | Director | San Francisco, CA |
| Petpiboon W Prasit | Director | South San Francisco, CA |
| Stella W Xu | Director | Shanghai, F4 |
| Robert W Weisskoff | Director | Cambridge, MA |
| Keting W Chu | Director | Wilmington, DE |
| Petpiboon J Prasit | Director | San Francisco, CA |
| Thomas J Woiwode | Director | San Francisco, CA |
| Michael J Raab | Director | San Francisco, CA |
| Stella J Xu | Director | San Francisco, CA |
| BRADLEY J BOLZON | Director | MENLO PARK, CA |
| THOMAS A COLL | Executive Officer | SAN DIEGO, CA |
Other filings by this issuer (3)
More